what's better for weight loss semaglutide or tirzepatide Why is a option than Both medications work. The real

Understanding these key differences can help you make an informed decision about effective weight management approaches that align with your health goals

In SURMOUNT-4 (Aronne et al., *JAMA* 2024), all patients ran an open-label phase reaching maximum tolerated dose (10 mg or 15 mg weekly) for 36 weeks, losing an average of 20.9% of body weight in that phase

Long-term follow-up of healthy people who met whipples triad criteria

Overall, GLP-1 agonists present a novel but manageable profile of ED-relevant toxicities

Real-world dosing requires flexibility, and the compounded format from Empower supports that flexibility far better than fixed-dose pens